Oncology

Adenocarcinoma of the cervix uteri

ORPHA:213772 ↗

Search all Adenocarcinoma of the cervix uteri trialsAlert me when a trial opens

studies recruiting now

as of 7 Sept 2026

studies registered in total

as of 7 Sept 2026

countries with a recruiting site

as of 7 Sept 2026

11 Dec 2025

most recent study posted

among recruiting studies

Recruiting trials

RecruitingNot applicableNCT01365169

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Sponsor M.D. Anderson Cancer CenterWhere United States (1 site)Studying Exercise Intervention, Health TelemonitoringUpdated 15 Jul 2026

See details

RecruitingPhase 2NCT07276360

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

Sponsor Uganda Cancer InstituteWhere Uganda (1 site)Studying Hypofractionated Radiation Therapy, Conventional Fractionated RadiotherapyUpdated 27 Mar 2026

See details

RecruitingPhase 2NCT06654011

IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial

Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWhere China (2 sites)Studying IN10018, Nab-paclitaxelUpdated 13 Jan 2026

See details

RecruitingPhase 1NCT05518253

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Sponsor Weijia Fang, MDWhere China (1 site)Studying CD70 CAR-T cells, CD70 CAR-T cellsUpdated 31 May 2025

See details

RecruitingNCT06196190

Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer

Sponsor Rambam Health Care CampusWhere Israel (1 site)Updated 9 Jan 2024

See details

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

See all 6 recruiting studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

China Israel Uganda United States

Keep watching

Get an email when a new Adenocarcinoma of the cervix uteri study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:213772 ↗

About Adenocarcinoma of the cervix uteri

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Orphanet expert page ↗GARD (NIH) ↗

Treatments being studied

17 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 3Cisplatin (Cisplatin)

Phase 3Paclitaxel (Abraxane)

Phase 2Sintilimab (Tyvyt)

Phase 2Tamoxifen

Phase 2Curcumin

Phase 2Letrozole (Femara)

Phase 2Ipilimumab (Yervoy)

Phase 2Irinotecan

+ 9 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).